mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.004 |